Mimotope discovery as a tool to design a vaccine against Zika and dengue viruses

Abstract

Vaccine development against dengue virus is challenging because of the antibody‐dependent enhancement of infection (ADE), which causes severe disease. Consecutive infections by Zika (ZIKV) and/or dengue viruses (DENV), or vaccination can predispose to ADE. Current vaccines and vaccine candidates contain the complete envelope viral protein, with epitopes that can raise antibodies causing ADE. We used the envelope dimer epitope (EDE), which induces neutralizing antibodies that do not elicit ADE, to design a vaccine against both flaviviruses. However, EDE is a discontinuous quaternary epitope that cannot be isolated from the E protein without other epitopes. Utilizing phage display, we selected three peptides that mimic the EDE. Free mimotopes were disordered and did not elicit an immune response. After their display on adeno‐associated virus (AAV) capsids (VLP), they recovered their structure and were recognized by an EDE‐specific antibody. Characterization by cryo‐EM and enzyme‐linked immunosorbent assay confirmed the correct display of a mimotope on the surface of the AAV VLP and its recognition by the specific antibody. Immunization with the AAV VLP displaying one of the mimotopes induced antibodies that recognized ZIKV and DENV. This work provides the basis for developing a Zika and dengue virus vaccine candidate that will not induce ADE.

Formation and Detection of Gizzerosine in Animal Feed Matrices: Progress and Perspectives

“…The current detection methods are costly, and synthetic methods of gizzerosine are scarce. ,, Moreover, the small size of the gizzerosine, and the presence of a rare secondary amine within the molecule complicate its labeling. ,, Recently, immunoassay technology based on anti-idiotype antibodies that can specifically bind to the antibody via imitating the epitope of the antigen and compete with the binding site of the analyte are used in immunodiagnosis, , pesticide residue detection, and vaccine development. , The marker of this assay is an easily labeled antibody, which makes the assay independent of hapten availability . The immunization of BALB/c mice with anti-gizzerosine mAb 3H4 conjugated to BC prepares 34 potential anti-idiotype antibodies.…”

Advanced cell technologies: Making protein, cell, and gene therapies a reality

“…In the area of vaccine development, Cuevas-Juárez et al (2023) applied phage display technology to produce epitopes (or mimotopes) that when attached to AAV virus-like particles (VLP) can produce an antibody response to recognize and potentially protect against zika and dengue viruses. In another study, Lorenzo et al (2023) described a process to purify HIV-1 Gag VLPs from contaminating host EVs using a series of downstream isolation stages including multiple filtration and chromatography steps.…”